Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country/Region, 2017, 2022 & 2028

2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Type

2.2.1 Serum Biomarkers

2.2.2 Hepatic Fibrosis Biomarkers

2.2.3 Apoptosis Biomarkers

2.2.4 Oxidative Stress Biomarkers

2.2.5 Others

2.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type

2.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

2.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue and Market Share by Type (2017-2022)

2.3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Type (2017-2022)

2.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Application

2.4.1 Pharma & CRO Industry

2.4.2 Hospitals

2.4.3 Diagnostic Labs

2.4.4 Academic Research Institutes

2.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application

2.5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Market Share by Application (2017-2022)

2.5.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue and Market Share by Application (2017-2022)

2.5.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Application (2017-2022)

3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers by Company

3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Breakdown Data by Company

3.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Company (2020-2022)

3.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Company (2020-2022)

3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Company (2020-2022)

3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Company (2020-2022)

3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company (2020-2022)

3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Company

3.4 Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Location Distribution

3.4.2 Players NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region

4.1 World Historic NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Geographic Region (2017-2022)

4.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Geographic Region (2017-2022)

4.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Geographic Region

4.2 World Historic NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Country/Region (2017-2022)

4.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Country/Region (2017-2022)

4.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Country/Region

4.3 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth

4.4 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth

4.5 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth

4.6 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth

5 Americas

5.1 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country

5.1.1 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)

5.1.2 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)

5.2 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type

5.3 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region

6.1.1 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2017-2022)

6.1.2 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region (2017-2022)

6.2 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type

6.3 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country

7.1.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)

7.1.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)

7.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type

7.3 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country

8.1.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)

8.1.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)

8.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type

8.3 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers

10.3 Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers

10.4 Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors

11.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customer

12 World Forecast Review for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region

12.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Region

12.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Region (2023-2028)

12.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Type

12.7 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Application

13 Key Players Analysis

13.1 GENFIT SA

13.1.1 GENFIT SA Company Information

13.1.2 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GENFIT SA Main Business Overview

13.1.5 GENFIT SA Latest Developments

13.2 Gilead Sciences, Inc. (GILD)

13.2.1 Gilead Sciences, Inc. (GILD) Company Information

13.2.2 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Gilead Sciences, Inc. (GILD) Main Business Overview

13.2.5 Gilead Sciences, Inc. (GILD) Latest Developments

13.3 AstraZeneca

13.3.1 AstraZeneca Company Information

13.3.2 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AstraZeneca Main Business Overview

13.3.5 AstraZeneca Latest Developments

13.4 Novartis AG

13.4.1 Novartis AG Company Information

13.4.2 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis AG Main Business Overview

13.4.5 Novartis AG Latest Developments

13.5 Bristol-Myers Squibb Company

13.5.1 Bristol-Myers Squibb Company Company Information

13.5.2 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Company Main Business Overview

13.5.5 Bristol-Myers Squibb Company Latest Developments

13.6 Allergan Plc

13.6.1 Allergan Plc Company Information

13.6.2 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Allergan Plc Main Business Overview

13.6.5 Allergan Plc Latest Developments

13.7 Novo Nordisk A/S

13.7.1 Novo Nordisk A/S Company Information

13.7.2 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novo Nordisk A/S Main Business Overview

13.7.5 Novo Nordisk A/S Latest Developments

13.8 Boehringer Ingelheim

13.8.1 Boehringer Ingelheim Company Information

13.8.2 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Boehringer Ingelheim Main Business Overview

13.8.5 Boehringer Ingelheim Latest Developments

13.9 Pfizer Inc

13.9.1 Pfizer Inc Company Information

13.9.2 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

13.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Pfizer Inc Main Business Overview

13.9.5 Pfizer Inc Latest Developments

14 Research Findings and Conclusion

Table 1. NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Serum Biomarkers

Table 4. Major Players of Hepatic Fibrosis Biomarkers

Table 5. Major Players of Apoptosis Biomarkers

Table 6. Major Players of Oxidative Stress Biomarkers

Table 7. Major Players of Others

Table 8. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)

Table 9. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

Table 10. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type (2017-2022) & ($ million)

Table 11. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2017-2022)

Table 12. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)

Table 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Table 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Application (2017-2022)

Table 16. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application (2017-2022)

Table 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Company (2020-2022) & (K Units)

Table 19. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Company (2020-2022)

Table 20. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Company (2020-2022) ($ Millions)

Table 21. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company (2020-2022)

Table 22. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Producing Area Distribution and Sales Area

Table 24. Players NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered

Table 25. NASH (Non-alcoholic Steatohepatitis) Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Geographic Region (2017-2022)

Table 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country/Region (2017-2022)

Table 34. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)

Table 37. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)

Table 38. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)

Table 40. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)

Table 41. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

Table 42. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)

Table 43. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Table 44. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2017-2022) & (K Units)

Table 45. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2017-2022)

Table 46. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Region (2017-2022)

Table 48. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)

Table 49. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

Table 50. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)

Table 51. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Table 52. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)

Table 53. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)

Table 54. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)

Table 56. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)

Table 57. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

Table 58. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)

Table 59. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Table 69. Key Market Challenges & Risks of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Table 70. Key Industry Trends of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Table 71. NASH (Non-alcoholic Steatohepatitis) Biomarkers Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors List

Table 74. NASH (Non-alcoholic Steatohepatitis) Biomarkers Customer List

Table 75. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Forecast by Region

Table 77. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Type (2023-2028)

Table 89. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Application (2023-2028)

Table 93. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Application (2023-2028)

Table 95. GENFIT SA Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 96. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 97. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. GENFIT SA Main Business

Table 99. GENFIT SA Latest Developments

Table 100. Gilead Sciences, Inc. (GILD) Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 101. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 102. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Gilead Sciences, Inc. (GILD) Main Business

Table 104. Gilead Sciences, Inc. (GILD) Latest Developments

Table 105. AstraZeneca Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 106. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 107. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. AstraZeneca Main Business

Table 109. AstraZeneca Latest Developments

Table 110. Novartis AG Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 111. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 112. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Novartis AG Main Business

Table 114. Novartis AG Latest Developments

Table 115. Bristol-Myers Squibb Company Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 116. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 117. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Bristol-Myers Squibb Company Main Business

Table 119. Bristol-Myers Squibb Company Latest Developments

Table 120. Allergan Plc Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 121. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 122. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Allergan Plc Main Business

Table 124. Allergan Plc Latest Developments

Table 125. Novo Nordisk A/S Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 126. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 127. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Novo Nordisk A/S Main Business

Table 129. Novo Nordisk A/S Latest Developments

Table 130. Boehringer Ingelheim Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 131. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 132. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Boehringer Ingelheim Main Business

Table 134. Boehringer Ingelheim Latest Developments

Table 135. Pfizer Inc Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 136. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered

Table 137. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Pfizer Inc Main Business

Table 139. Pfizer Inc Latest Developments

List of Figures

Figure 1. Picture of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Figure 2. NASH (Non-alcoholic Steatohepatitis) Biomarkers Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Serum Biomarkers

Figure 10. Product Picture of Hepatic Fibrosis Biomarkers

Figure 11. Product Picture of Apoptosis Biomarkers

Figure 12. Product Picture of Oxidative Stress Biomarkers

Figure 13. Product Picture of Others

Figure 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type in 2021

Figure 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2017-2022)

Figure 16. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Pharma & CRO Industry

Figure 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Pharma & CRO Industry (2017-2022) & (K Units)

Figure 18. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Hospitals

Figure 19. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Hospitals (2017-2022) & (K Units)

Figure 20. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Diagnostic Labs

Figure 21. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Diagnostic Labs (2017-2022) & (K Units)

Figure 22. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Academic Research Institutes

Figure 23. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Academic Research Institutes (2017-2022) & (K Units)

Figure 24. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)

Figure 25. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application in 2021

Figure 26. NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market by Company in 2021 ($ Million)

Figure 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company in 2021

Figure 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Geographic Region in 2021

Figure 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2017-2022)

Figure 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country/Region in 2021

Figure 32. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)

Figure 33. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)

Figure 34. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)

Figure 35. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)

Figure 36. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)

Figure 37. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)

Figure 40. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021

Figure 41. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021

Figure 42. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region in 2021

Figure 47. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions in 2021

Figure 48. China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 52. India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021

Figure 55. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021

Figure 56. Germany NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 57. France NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021

Figure 62. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021

Figure 63. Egypt NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2021

Figure 69. Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Figure 70. Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles